| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |